Bayer stock plunges days after jury awards $289 million to man with terminal cancer
by from on (#3WQBD)
Bayer's stock slumped more than 11 percent in premarket trading Monday, three days after a California jury awarded $289 million to a former groundskeeper who said the popular weedkiller Roundup gave him terminal cancer.